
Ryon Pharma and Infra Private Limited
About Ryon Pharma and Infra Private Limited
Data last updated:
Ryon Pharma and Infra Private Limited is a private limited company based in Tirupati, Andhra Pradesh, India. It operates in the advocacy segment of the professional services sector. It was incorporated on 11 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74110AP2016PTC103846. Its GSTIN is 36AAHCR8926J1ZT (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Ryon Pharma Private Limited. It is led by directors Kartheek Ganji and Naresh Kumar Ganji.
Its last annual general meeting (AGM) was held on 30 December 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at D.No.18 – 1 – 293/8 Ground Floor Bhavani Nagar, Tirupati, Andhra Pradesh, India – 517501.
As per the financials filed for FY 2019, the company reported a revenue of ₹20.52 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹39,249 (net margin 1.9%) and EBITDA of ₹1.1 Lakh (EBITDA margin 5.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Ryon Pharma and Infra has one previous CIN (Corporate Identification Number): U74999AP2016PTC103846. The current CIN is U74110AP2016PTC103846, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110AP2016PTC103846 | Current |
| U74999AP2016PTC103846 | Previous |
Contact details
Ryon Pharma and Infra Private Limited's registered office is in Tirupati, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No.18 – 1 – 293/8 Ground Floor Bhavani Nagar, Tirupati, Andhra Pradesh, India – 517501
- IndustryProfessional Services, Advocacy, Legal Services, Tax Consultant, Accounting
To see the full contact details of Ryon Pharma and Infra Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ryon Pharma and Infra is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Ryon Pharma and Infra Private Limited, buy the company report.
Financials of Ryon Pharma and Infra Private Limited
FY 2019 filings availableRyon Pharma and Infra Private Limited reported revenue of ₹20.52 Lakh (up 218% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 218% in the latest year. EBITDA rose 123% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹20.52 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.1 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹39,249 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.3% | ||
| Net Profit Margin | 1.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ryon Pharma and Infra Private Limited, buy the company report.
Board of directors of Ryon Pharma and Infra Private Limited
Ryon Pharma and Infra has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kartheek Ganji | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
| Naresh Kumar Ganji | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Ryon Pharma and Infra Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mithraa Nature Cure Private Limited | ₹20.57 Lakh (FY 2020) | Chennai, Tamil Nadu, India | ||||
| Helping Hands Animal Welfare Foundation | ₹20.55 Lakh (FY 2025) | 310.0% | Mumbai, Maharashtra, India | |||
| S.Shankar Healthcare Private Limited | ₹20.54 Lakh (FY 2025) | -14.0% | Delhi, India | |||
| Ayush Dhatri Wellness Private Limited | ₹20.54 Lakh (FY 2022) | Delhi, India | ||||
| Star Medicare World Tourism Private Limited | ₹20.53 Lakh (FY 2024) | 106.0% | Delhi, India | |||
| Ryon Pharma and Infra Private Limitedthis company | ₹20.52 Lakh (FY 2019) | ₹39,249 | 1.9% | 218.0% | Tirupati, Andhra Pradesh, India | |
| Saibins Sourcing & Services (OPC) Private Limited | ₹20.49 Lakh (FY 2025) | 29.0% | Rupnagar, Punjab, India | |||
| Dr Nayak Dialysis Centres Private Limited | ₹20.47 Lakh (FY 2016) | Hyderabad, Telangana, India | ||||
| Powercure Pharmaceuticals Private Limited | ₹20.46 Lakh (FY 2016) | 1101.0% | Yelahanka, Karnataka, India | |||
| Azurite Therapeutics Private Limited | ₹20.43 Lakh (FY 2025) | -25.0% | Pune, Maharashtra, India | |||
| Vijaya Women Welfare Foundation | ₹20.4 Lakh (FY 2024) | 6.0% | Howrah, West Bengal, India |
To see the full peer comparison of Ryon Pharma and Infra Private Limited, buy the company report.
Auditor
Ryon Pharma and Infra Private Limited is audited by A ZARINA BANU for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A ZARINA BANU | FY 2017 | 230442 |
Shareholding
The shareholding of Ryon Pharma and Infra Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ryon Pharma and Infra Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ryon Pharma and Infra Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ryon Pharma and Infra Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ryon Pharma and Infra has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCR8926J1ZT | Telangana | Active | 26 Dec 2017 |
To see the full GST registrations and return filing status of Ryon Pharma and Infra Private Limited, buy the company report.
Recent activity
Ryon Pharma and Infra Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Parvathi Kathula ceased to be Director on 09 Mar 2018.
Frequently asked questions
Ryon Pharma and Infra is an active private limited company based in Tirupati, Andhra Pradesh, India. The company works in advocacy, within the professional services industry. It was incorporated on 11 August 2016 (10+ years old) and is registered under CIN U74110AP2016PTC103846.
Ryon Pharma and Infra has 2 current directors:
- Kartheek Ganji - Director
- Naresh Kumar Ganji - Director
The latest financial statements of Ryon Pharma and Infra on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 December 2019. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ryon Pharma and Infra is 36AAHCR8926J1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Ryon Pharma and Infra is U74110AP2016PTC103846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ryon Pharma and Infra was incorporated on 11 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Ryon Pharma and Infra by revenue are Mithraa Nature Cure Private Limited, Helping Hands Animal Welfare Foundation, S.Shankar Healthcare Private Limited, Ayush Dhatri Wellness Private Limited, Star Medicare World Tourism Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Parvathi Kathula ceased to be Director on 09 Mar 2018. Vijay Kumar Rudra ceased to be Director on 09 Mar 2018. Kartheek Ganji was appointed as Director on 11 Aug 2016. Ryon Pharma and Infra has 4 board changes on record in total.
The registered office of Ryon Pharma and Infra is at D.No.18 – 1 – 2938 Ground Floor Bhavani Nagar, Tirupati, Andhra Pradesh, India – 517501.
Ryon Pharma and Infra operates in the professional services industry, in the advocacy segment.
The compliance status of Ryon Pharma and Infra is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.

